Mean IL-1Ra expression reached and maintained target levels in synovial fluid throughout six-month follow-up period Immune-conditioning with short steroid course supported higher levels of transgene expression Results will guide design of Phase 2 study and discussion with regulatory...
Read More Details
Finally We wish PressBee provided you with enough information of ( Genascence Announces Six-Month Results from Phase 1b DONATELLO Trial Indicating GNSC-001 Was Safe and Well Tolerated Across Multiple Dosing Arms )
Also on site :
- Target's 'Top-Selling' $5 Backpack Is Heading Back to Stores This Year
- Fresh sirens in north Israel warning of Iran missiles: army
- Music Icon's Rarely Seen Daughter, 77, Photographed in Los Angeles